Aditxt, Inc. (NASDAQ:ADTX) Sees Large Increase in Short Interest

Aditxt, Inc. (NASDAQ:ADTX) was the target of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 1,040,000 shares, an increase of 14.2% from the October 31st total of 910,800 shares. Currently, 7.3% of the company’s shares are sold short. Based on an average daily trading volume, of 2,690,000 shares, the short-interest ratio is presently 0.4 days.

Aditxt Trading Up 6.2 %

ADTX opened at $0.37 on Monday. Aditxt has a twelve month low of $0.31 and a twelve month high of $380.00. The company has a fifty day moving average of $1.71 and a 200-day moving average of $34.90.

Insider Buying and Selling

In other news, major shareholder Financial Lp Hrt sold 25,534 shares of the firm’s stock in a transaction dated Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total transaction of $29,874.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.72% of the stock is owned by corporate insiders.

About Aditxt

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.